+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Colonoscopes-Pipeline Insight and Competitive Landscape, 2022

  • PDF Icon

    Drug Pipelines

  • 60 Pages
  • July 2022
  • Region: Global
  • DelveInsight
  • ID: 5525554
This “Colonoscopes-Pipeline Insight and 2022,” report provides comprehensive insights about 20+ companies and 20+ pipeline devices in Colonoscopes pipeline landscape. Colonoscope is inserted into the rectum, to examine the inside of the colon. A colonoscope is a thin, tube-like instrument with a visible light and a lens. It may also have a tool for removing tissue for signs of illness to be checked under a microscope. Fewer people will die from colorectal cancer if healthcare professionals accept a new screening method that incorporates better risk analysis, more non-invasive treatment option and more aimed colonoscopy referrals & this will definitely increase the demand which will eventually lead to increased market boost.

Geography Covered

  • Global coverage
Colonoscopes Overview

Colonoscopes: Understanding


Colonoscopes are used for the removal of foreign bodies, excision of tumors or colorectal polyps (polypectomy), and control of hemorrhage. Routine colonoscopy is important in diagnosing intestinal cancer, the second leading cause of cancer deaths in the United States. These endoscopic procedures reduce the need for invasive surgical diagnostic and therapeutic procedures. There are two types of Colonoscopes: Video and fiberoptic.

Principles of operation
Video colonoscope insertion tubes contain a fi beroptic light bundle, which transmits light from the light source to the tip of the endoscope. Each fi beroptic bundle consists of thousands of individual glass fi bers coated with glass causing internal refl ections that allow light transmission through the fi ber even when it is fl exed. The light is used to illuminate the fi eld of view in the patient's colon. Video images are detected by the CCD and are then transmitted to the video processor and then display monitors or recording devices.

Colonoscopes Competitive Assessment


This segment of the Colonoscopes report encloses its detailed analysis of various pipeline devices which include product description, licensing and collaboration details and other developmental activities including pipeline territories, regulatory paths and estimated approval dates and the latest news and press releases. The report also provides list of major players involved in the pipeline product development. 
  • Product Type
Colonoscopes can be used in two different ways - Video and fiberoptic, both the ways are covered in the report.
  • Major Players in Colonoscopes
There are approx. 20+ key companies which are developing the products for Colonoscopes.
  • GI Genius intelligent endoscopy module: Cosmo Pharmaceuticals
The GI Genius intelligent endoscopy module offers a transformative solution - powered by artificial intelligence - to address the challenges of detecting colorectal cancer, early. It works as an adjunct to the gastroenterologist during a colonoscopy with the purpose of highlighting regions with visual characteristics consistent with different types of mucosal abnormalities, such as colorectal polyps of all shapes, sizes, and morphology.
  • Saneso's 360º colonoscope: Saneso
Saneso's 360º colonoscope with a traditional forward camera only colonoscope demonstrate that Saneso significantly increases polyp detection. This increased polyp detection with Saneso's 360º colonoscope was found among endoscopists with varying levels of experience and practice settings. Saneso 5-camera endoscopes provide an unprecedented integrated 360° view of the GI tract that is easily and intuitively interpreted.

Further product details are provided in the report……..

Colonoscopes Competitive Benchmarking
This segment of the reports provides analysis of the pipeline report to give a clear understanding of the comparative analysis.

The analysis is based on
  • Brand Positioning of Leading companies
  • Application
  • Industry Collaborations
Colonoscopes: Commercialization Activity
This segment of the report provides a detailed list of any commercial activity in the field of colonoscopes devices ranging from collaboration, mergers and acquisition, recent breakthrough among others.

Development Activities
  • July 2020, new research indicates that mailing colorectal cancer screening kits to Medicaid enrollees is a cost-effective way to boost screening rates. The findings are published early online in CANCER, a peer-reviewed journal of the American Cancer Society (ACS). The findings are especially timely considering the recent need for alternatives to face-to-face visits with physicians during the COVID-19 pandemic.
  • March 2020, The United States Multi-Society Task Force on Colorectal Cancer has issued updated guidelines on follow-up after colonoscopy and polypectomy. Notable changes are that for patients with 1 to 2 small (< 10 mm) tubular adenomas, the recommended surveillance interval is 7 to 10 years (previously 5 to 10 years), and for individuals with 3 to 4 small tubular adenomas, it is 3 to 5 years (previously 3 years). For individuals with >10 adenomas on a single examination, the surveillance interval is 1 year (previously 3 years) and genetic evaluation is suggested for any individual with >10 adenomas cumulatively over their lifetime.
Further commercial activities are provided in the report……..

Colonoscopes: Regulatory
The device, when intended as an endoscope disinfectant basin, which consists solely of a container that holds disinfectant and endoscopes and accessories, is exempt from the premarket notification procedures in part 807, subpart E, of this chapter subject to the limitations in 876.9 under CFR - Code of Federal Regulations Title 21.

Further information is provided in the report……..

Report Highlights

  • Extensive coverage of the Colonoscopes under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Colonoscopes and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry
  • The report consists of in depth analysis of pipeline products based on various parameters
Colonoscopes Report Insights
  • Colonoscopes - Pipeline Analysis
  • Colonoscopes - Unmet Need
  • Colonoscopes - Market Dynamics
  • Colonoscopes - Future Perspectives and Conclusion
  • Colonoscopes - Analyst Views

Key Questions

  • What are significant companies in this segment, their information, analysis, and insights to improve R&D strategies?
  • How to identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage?
  • What are important and diverse types of Colonoscopes under development?
  • What are market-entry and market expansion strategies in Colonoscopes?
  • What are some of the mergers and acquisitions and to identify major players with the most promising pipeline?
  • What is in-depth analysis of the product's current stage of development, territory and estimated launch date?
Key Players
  • Consis Medical Inc
  • Cosmo Pharmaceuticals NV
  • Ethicon Endo-Surgery Inc
  • Image In
  • Inmotion Medical Ltd
  • invendo medical GmbH
  • Kaleidoscope
  • Medigus Ltd
  • Microbot Medical Ltd
  • Novadaq Technologies Inc
  • Olympus Corp
  • Omniscient LLC
  • Saneso Inc
  • SMART Medical Systems Ltd
  • SpectraCyte LLC

Table of Contents

1. Key Insights

2. Colonoscopes: Snapshot

3. Colonoscopes
3.1. Product Overview
3.2. Regulatory Approvals based on Class
3.3. Indications
3.4. Mechanism

4. Colonoscopes: Competitive Assessment
4.1. Assessment by Product Type
4.1.1. Video
4.1.2. Fiberoptic
4.2. Assessment by Company
4.2.1. Cosmo Pharmaceuticals
4.2.1.1. GI Genius intelligent endoscopy module: Cosmo Pharmaceuticals
4.2.1.1.1. Product Information
4.2.1.1.2. Research and Development
4.2.1.1.3. Patent Details
4.2.1.1.4. Regulatory Milestone
4.2.2. Saneso
4.2.2.1. Saneso's 360º colonoscope: Saneso
4.2.2.1.1. Product Information
4.2.2.1.2. Research and Development
4.2.2.1.3. Patent Details
4.2.2.1.4. Regulatory Milestone
*More Companies and products would be added in the final report

5. Colonoscopes: Competitive Benchmarking: By Company
5.1. Brand Positioning of Leading companies
5.2. Analysis based on Application
5.3. Analysis based on Industry Collaborations

6. Colonoscopes - Commercialization Activity
6.1. Collaboration
6.2. Licensing
6.3. Merger and Acquisition
6.4. Recent Breakthroughs
6.5. Literature Studies
6.6. KOL Views

7. Colonoscopes: Regulatory
7.1. US
7.2. Europe
7.3. Japan

8. Colonscopes: Regulatory
8.1. Case Study - US
8.2. Case Study - Europe
8.3. Case Study -Japan

9. Colonoscopes: Market Dynamics
9.1. Unmet Needs
9.2. Market Drivers
9.3. Market Barriers

10. Analytical Perspective
10.1. PEST Analysis
10.2. Future Growth Perspectives

11. Conclusion

12. Appendix
12.1. Research Methodology
12.1.1. Coverage
12.1.2. Secondary Research

13. Bibliography

14. Publisher Capabilities

15. Disclaimer

16. About the PublisherList of Tables
Table 1 Total Pipeline Products
Table 4 Pipeline Products by Type
Table 6 List of Companies
Table 8 Saneso Pipeline Products & Ongoing Clinical Trials Overview
Table 10 Saneso’s 360º colonoscope- Product Status
Table 12 Saneso’s 360º colonoscope - Product Description
Table 14 Cosmo Pharmaceuticals Pipeline Products & Ongoing Clinical Trials Overview
Table 16 GI Genius intelligent endoscopy module- Product Status
Table 18 GI Genius intelligent endoscopy module - Product Description List of Figures
Figure 1 List of Pipeline Products
Figure 3 Ongoing Clinical Trial Pipeline Products by Product Type
Figure 4 Ongoing Clinical Trial Pipeline Products by Company

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Consis Medical Inc
  • Cosmo Pharmaceuticals NV
  • Ethicon Endo-Surgery Inc
  • Image In
  • Inmotion Medical Ltd
  • invendo medical GmbH
  • Kaleidoscope
  • Medigus Ltd
  • Microbot Medical Ltd
  • Novadaq Technologies Inc
  • Olympus Corp
  • Omniscient LLC
  • Saneso Inc
  • SMART Medical Systems Ltd
  • SpectraCyte LLC